TheraMe! High impact

News

20.2.2025

01.11.2025

We have finalized our first fully integrated alpha prototype for microfluidic drug testing. This major milestone brings us closer to delivering a scalable IVD product for patient-specific therapy testing

TheraMe! has obtained ISO 13485 certification for design and development of its products. This certification validates our commitment to the highest international standards in medical device quality and risk management

23.01.2025

10.12.2024

It was a privilege to pitch at the EPFL Investor Day event, where we gained valuable insights, built strategic relationships

01.11.2024

We are excited to welcome Mehmet Sehir to our team as a Bioinformatician, bringing his skills in NGS data analysis and algorithm development

25.04.2024

24.01.2024

TheraMe! is awarded an Innosuisse grant for the development of an industry prototype in collaboration with CSEM

15.12.2023

TheraMe! unveils an enhanced prototype for streamlined IVD screens

11.05.2023

14.04.2022

01.11.2021

01.11.2025

Dr. Emmanuel Delamarche has joined TheraMe! as an Industry Advisor. A leading expert in microfluidics and diagnostics, he brings decades of experience in translating innovation into real-world applications

16.08.2021

15.10.2025

We welcome three new team members to TheraMe!. Their expertise will strengthen our innovation and help drive the next stage of growth

Publications